Log in to search using one of your social media accounts:

 

Medical News Today: Chronic or persistent A-fib: What you need to know
Chronic atrial fibrillation can cause dizziness, heart palpitations, and fatigue. Learn more about this long-term cardiac condition. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 17, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Botox Injections to the Heart May Tamp Down Postop AF Botox Injections to the Heart May Tamp Down Postop AF
Epicardial injections of the neurotoxin appeared safe and reduced early postoperative atrial fibrillation by 11% compared with saline injections.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Anticoagulation in Patients With AF and Prior Hemorrhage Anticoagulation in Patients With AF and Prior Hemorrhage
Determining the optimal treatment approach for patients with atrial fibrillation who have had a brain hemorrhage remains extremely challenging. How can we balance risk vs. benefit?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 15, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Clinical outcomes and history of fall in patients with atrial fibrillation treated with oral anticoagulation: insights from the ARISTOTLE Trial - Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB.
PURPOSE: We assessed outcomes among anticoagulated patients with atrial fibrillation (AF) and a history of falling, and whether the benefits of apixaban versus warfarin are consistent in this population. METHODS: Of the 18,201 patients in ARISTOTLE... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

BMS-Pfizer Alliance to unveil real-world data analyses - cost, safety and comparative effectiveness findings associated with oral anticoagulants in non-valvular atrial fibrillation
Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) plan to release real-world data (RWD) analyses of outcomes associated with direct oral anticoagulants (DOAC) among non-valvular atrial fibrillation (NVAF) patients using the U.S. Medicare database - the nation's largest insurer handling more than one billion total claims per year(1) (Source: World Pharma News)
Source: World Pharma News - November 10, 2017 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news

Being overweight taxes your heart, increasing risk of disease, death
(Natural News) A new study reveals that putting on extra weight can substantially alter the size of your heart, increasing the risk of heart attack or stroke. A bigger, heavier heart stretches its upper chambers, causing atrial fibrillation, or irregular heartbeats. The chances of you carrying excess weight is increased when you consume high amounts... (Source: NaturalNews.com)
Source: NaturalNews.com - November 10, 2017 Category: Consumer Health News Source Type: news

Planning to travel with atrial fibrillation?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - November 8, 2017 Category: Consumer Health News Source Type: news

More active older women have lower mortality
Higher volumes and intensity of physical activity linked to lower mortality in older women Related items fromOnMedica Diet, lifestyle and cardiovascular disease Moderate exercise improves over-50s ’ brain health Never too old to benefit from CVD prevention Real food and brisk daily walk best for heart health Atrial fibrillation poses greater risk for women than men (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 7, 2017 Category: UK Health Source Type: news

Irregular heartbeat? THIS hidden heart condition has been linked to higher DEATH risk
AN IRREGULAR heartbeat is known as atrial fibrillation, and the common condition has been linked by researchers to a higher death risk in some sufferers. (Source: Daily Express - Health)
Source: Daily Express - Health - November 2, 2017 Category: Consumer Health News Source Type: news

TCT 2017: Boston Scientific touts lowered hemorrhagic stroke rate, cost for patients in Watchman studies
Boston Scientific (NYSE:BSX) today released combined 5-year outcomes data from both the Prevail and Protect-AF study of its Watchman left atrial appendage closure device, touting it as a safe and effective an alternative to long-term warfarin therapy for patients with non-valvular atrial fibrillation. Five-year data from the Prevail study was published online today in the Journal of the American College of Cardiology. In both trials, the Marlborough, Mass.-based company compared the Watchman device to warfarin treatment for stroke prevention in patients with non-valvular AF with follow-ups out to five years. A combine...
Source: Mass Device - November 2, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news

Anticoagulant Reversal Drugs Stop Patient's Internal Hemorrhage
Pharmacology to the tune of anticoagulant reversal Your EMS flight crew is dispatched by rotor to a remote hospital in the Great Basin Desert for a patient with gastrointestinal (GI) bleeding. The patient was brought in by her grandson. She was vomiting blood as well as suffering from bloody diarrhea. On arrival, you find an 80-year-old female sitting up in a hospital bed, although she's extremely weak. She has a Glasgow coma scale (GCS) of 15 and states she's been throwing up blood all day. She appears pale but is in no obvious distress. Her vital signs are a heart rate of 100 with regular pulse; blood pressure 60/35 mmHg...
Source: JEMS Patient Care - November 2, 2017 Category: Emergency Medicine Authors: Brant Jaouen, MD Tags: Patient Care Columns Source Type: news

Stratifying Stroke Risk in AF: Beyond Clinical Risk Scores Stratifying Stroke Risk in AF: Beyond Clinical Risk Scores
This review summarizes the various methods and markers which go beyond clinical risk scores for predicting stroke risk in patients with atrial fibrillation.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 1, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Automatic Blood Pressure Monitor Accurately Detects AF
Automatic blood pressure screening with a blood pressure monitor can accurately detect new cases of atrial fibrillation (AF) among older populations, according to a recent U.S. study. (Source: Caring for the Ages)
Source: Caring for the Ages - October 28, 2017 Category: Health Management Authors: Braxton Poe Source Type: news

Afternoon open heart surgery 'leads to fewer complications'
Conclusion This study found evidence of an effect that's worth investigating further to see if there are real differences in heart muscle function and risk of complications from heart surgery at different times of the day. However, there were some limitations: It took place at a single hospital, with a relatively small number of people undergoing operations. The laboratory study found differences in gene activity that suggested the body clock may play a role in making the heart better able to tolerate loss of oxygen and subsequent re-oxygenation. However, there may be other explanations for these differences. For example, ...
Source: NHS News Feed - October 27, 2017 Category: Consumer Health News Tags: Heart/lungs Source Type: news

How often does your heart skip a beat? The answer may explain why fewer blacks have AF than whites
(Elsevier) Recent studies have determined that blacks have a lower risk of atrial fibrillation (AF) compared with whites despite having a higher prevalence of risk factors such as hypertension and heart failure. A new study found evidence that blacks experience statistically significantly fewer premature atrial contractions but with similar frequencies of premature ventricular contractions. Both are common causes of early, skipped, or irregular heartbeats. This difference in atrial ectopy by race may help explain the substantial differences in AF rates between blacks and whites. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 27, 2017 Category: International Medicine & Public Health Source Type: news

Public awareness of atrial fibrillation is low
(Wiley) In a Research and Practice in Thrombosis and Haemostasis study that surveyed the general public in 10 countries, only 48% of people were aware of atrial fibrillation (AF), which is lower than the awareness of other common diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 27, 2017 Category: International Medicine & Public Health Source Type: news

Blood Thinners May Protect A-Fib Patients' Brains
Blood thinners may pull double duty for people with the heart rhythm disorder atrial fibrillation: New research suggests they help prevent dementia as well as stroke. (Source: WebMD Health)
Source: WebMD Health - October 26, 2017 Category: Consumer Health News Source Type: news

Blood Thinners May Also Protect Brains of A-Fib Patients
Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Dementia (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 26, 2017 Category: Consumer Health News Source Type: news

Blood Thinners May Also Protect Brains of A-Fib Patients
THURSDAY, Oct. 26, 2017 -- Blood thinners may pull double duty for people with the heart rhythm disorder atrial fibrillation: New research suggests they help prevent dementia as well as stroke. Because atrial fibrillation increases the risk for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 26, 2017 Category: General Medicine Source Type: news

High-Normal Free Thyroxine Linked to Atrial-Fibrillation Risk High-Normal Free Thyroxine Linked to Atrial-Fibrillation Risk
A systematic review found no link, however, between AF risk and thyroid-stimulating hormone levels in the normal or subclinical hypothyroid range.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 25, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Blood-thinning drugs may reduce dementia risk in people with irregular heartbeats
Conclusion If you’ve been diagnosed with AF and you have been prescribed anticoagulant treatments such as warfarin or clopidogrel, we already know they protect you against having a stroke. This study suggests they may also help to protect you against dementia. Cutting the risk of dementia for people who have a raised risk because of AF would be an exciting step forward. Unfortunately, we can’t tell from this study whether the protection against dementia was down to the anticoagulants, because of the possible effect of unmeasured confounding factors. Usually, we would want to see a randomised controlled trial (R...
Source: NHS News Feed - October 25, 2017 Category: Consumer Health News Tags: Neurology Source Type: news

Research finds blood-thinning drugs may reduce dementia risk, Alzheimer's Society comments
New research published today suggests that blood-thinning drugs may be associated with reduction in dementia risk, as well as reducing the risk of stroke in patients with atrial fibrillation (AF). (Source: Alzheimers Society)
Source: Alzheimers Society - October 25, 2017 Category: Geriatrics Source Type: news

Medical News Today: Blood thinners slash dementia risk in A-fib patients
A new study suggests that anticoagulants - old and new - may have a protective effect against dementia in patients with atrial fibrillation. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 25, 2017 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news

Oral Anticoagulants Tied to Less Dementia in Patients with Atrial Fibrillation (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Oral anticoagulation in patients with atrial fibrillation is associated with reduced risk for dementia, according to a retrospective study in the European Heart Journal.Using data … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - October 25, 2017 Category: Primary Care Source Type: news

Anticoagulants protect against dementia in AF patients, study finds
Patients with atrial fibrillation (AF) should be told anticoagulants protect against dementia to help convince them to take, and continuing using, their medication, researchers have said. (Source: GP Online News)
Source: GP Online News - October 24, 2017 Category: Primary Care Tags: Atrial fibrillation Source Type: news

Irregular heartbeat may be tied to elevated thyroid levels
A review of 11 studies from Australia, Europe and the United States found that patients with atrial fibrillation have higher levels of thyroid hormone. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 23, 2017 Category: Consumer Health News Source Type: news

Free thyroxine levels linked to atrial fibrillation
According to a new study published inCirculation, higher levels of thyroid hormone in the bloodstream are associated with a higher risk of atrial fibrillation.EurekAlert! (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 23, 2017 Category: Endocrinology Source Type: news

Apixaban -- metabolism, pharmacologic properties and drug interactions
(Bentham Science Publishers) New oral anticoagulants (NOACs) represent direct-acting drugs functioning selectively for one specific clotting factor. Their clinical indications are the prophylaxis and treatment of deep venous thrombosis and pulmonary embolism, the prevention of atherothrombotic episodes of individuals with acute coronary syndromes and atrial fibrillation (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2017 Category: International Medicine & Public Health Source Type: news

Avoiding Alcohol Helps the Heart Beat Better
Each decade of teetotaling lowers risk of atrial fibrillation, study finds (Source: WebMD Health)
Source: WebMD Health - October 18, 2017 Category: Consumer Health News Source Type: news

Avoiding Alcohol Helps the Heart Beat Better
WEDNESDAY, Oct. 18, 2017 -- The longer you refrain from drinking, the lower your risk of a common heart rhythm disorder. That's the message of a new long-range study examining alcohol use and atrial fibrillation, or Afib. This is when electrical... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 18, 2017 Category: General Medicine Source Type: news

Newer Blood Thinners May Not Bring Higher Bleeding Risk
Risk is similar to warfarin, study reports Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners, Deep Vein Thrombosis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 18, 2017 Category: Consumer Health News Source Type: news

Superior vena cava(SVC)-derived atrial fibrillation attributes clinical and genetic factor
This study has successfully demonstrated that AF is associated with both clinical and genetic factors. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 18, 2017 Category: International Medicine & Public Health Source Type: news

Drug-Drug Interactions with DOACs: Proceed with Caution!
Which drugs taken concurrently with the new oral anticoagulants put patients with Afib at greatest increased risk for major bleeding? (Source: ConsultantLive)
Source: ConsultantLive - October 16, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news

Atrial Fibrillation and Type I Diabetes: What & #039;s the Link?
A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences. (Source: ConsultantLive)
Source: ConsultantLive - October 16, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Diabetes Source Type: news

Study: Men develop atrial fibrillation a decade earlier than women
Men can develop atrial fibrillation, a type of irregular heartbeat, significantly earlier than women and researchers found that weight is a major factor. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 16, 2017 Category: Consumer Health News Source Type: news

Medical News Today: A-fib strikes men a decade earlier than women
New research shows that atrial fibrillation develops in men 10 years earlier on average than in women, and that excess weight is also a factor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 16, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

A-Fib Hits Men Earlier Than Women
Excess weight also ups risk for the heart rhythm disorder, study says Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Men's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 16, 2017 Category: Consumer Health News Source Type: news

A-Fib Hits Men Earlier Than Women
MONDAY, Oct. 16, 2017 -- Men develop a dangerous type of irregular heartbeat called atrial fibrillation a decade earlier than women, a new study suggests. And while being overweight increased odds for the condition in both sexes, those extra pounds... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 16, 2017 Category: General Medicine Source Type: news

Boston Scientific closes Apama Medical buy
Boston Scientific (NYSE:BSX) today announced it closed its acquisition Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation in a deal that could be worth $300 million. The deal, which Boston Scientific announced last Monday, includes an initial $175 million in cash up-front from the Marlborough, Mass.-based company and an additional $125 million in contingent payments between 2018 and 2020 based on clinical and regulatory milestones. The closure comes in ahead of schedule, according to an SEC filing, officially closing on Tuesday. Boston Scientific originally exp...
Source: Mass Device - October 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Catheters Mergers & Acquisitions Boston Scientific Source Type: news

Digital health news briefs for 10/11/2017
Patient, provider atrial fibrillation apps launch. Two new smartphone and tablet apps targeting atrial fibrillation and designed by the European Society of Cardiology (ESC) and the University of Birmingham have launched for free on the iOS  App Store and Google Play store. (Source: mobihealthnews)
Source: mobihealthnews - October 11, 2017 Category: Information Technology Source Type: news

Smartphone and tablet apps launched for patients with heart rhythm disorder
(University of Birmingham) New novel smartphone and tablet apps for patients with atrial fibrillation and healthcare professionals have been launched by heart experts in collaboration with the University of Birmingham. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 11, 2017 Category: International Medicine & Public Health Source Type: news

Smartphone apps launched to help atrial fibrillation patients
Researchers have developed new smartphone and tablet apps to help patients with atrial fibrillation and their doctors better manage their condition. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 10, 2017 Category: Consumer Health News Source Type: news

Smartphone Apps Launched for Atrial Fibrillation Patients and their Healthcare Providers
The objectives and design of the apps are outlined in a paper published online today in EP Europace,(1) with a summary published in the European Heart Journal.(2) (Source: eHealth News EU)
Source: eHealth News EU - October 10, 2017 Category: Information Technology Tags: Featured Development Research and Development Source Type: news

Smartphone apps launched for atrial fibrillation patients and their healthcare providers
The objectives and design of the apps are outlined in a paper published online today in EP Europace,1 with a summary published in the European Heart Journal.2 (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 10, 2017 Category: International Medicine & Public Health Source Type: news

Medical News Today: Nonvalvular atrial fibrillation: Get the facts
Learn about nonvalvular atrial fibrillation here. How does it differ from other forms of A-fib? What are the risks, symptoms, and treatment options? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 9, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Cardiologs raises $6m in Series A to support ECG Analysis Platform
Cardiologs Technologies said this week it raised $6.4 million in a Series A round of financing to support accelerated commercialization of its Cardiologs ECG Analysis Platform in the US and Europe. Funding in the round came from a syndicate of new investors including Idinvest, ISAI, Kurma Partners and Partech and was joined by the previously vested Bpifrance seed fund. The funds bring the total raised for the Paris-based company up to $10 million. “Cardiologs is the perfect example of applying state-of-the-art machine learning techniques to help professionals work much faster and more accurately. And in this cas...
Source: Mass Device - October 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Diagnostics cardiologstechnologies Source Type: news

FDA clears Peerbridge Health ’ s Cor wireless ECG monitor
Health information technology company Peerbridge Health said this week it won FDA 510(k) clearance for its Peerbridge Cor wireless electrocardiogram monitor. The New York-based company claims the Cor has the smallest on-body footprint of any wearable monitor and provides multiple channels of ECG through water-resistant electrodes to enable continuous monitoring. Data from a clinical trial of the Cor device, carried out at New York’s Northwell Health System’s Lenox Hill Hospital, indicated that the wireless monitor was superior to a Holter Monitor, Peerbridge Health claims. “Early detection of atrial fibri...
Source: Mass Device - October 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiovascular Diagnostics Food & Drug Administration (FDA) peerbridgehealth Source Type: news

Registry data examines oral anticoagulant use in women, adverse events after PCI discharge
(American College of Cardiology) Data from the American College of Cardiology's National Cardiovascular Data Registry was the source of several published studies in recent months, including a study on predicting 30-day readmission rates for patients undergoing percutaneous coronary intervention and a study that found women were less likely to use oral anticoagulants to treat atrial fibrillation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 5, 2017 Category: International Medicine & Public Health Source Type: news

Will Apama Help Bos Sci Find Its Rhythm?
Boston Scientific has struggled to gain share in the $4.4 billion electrophysiology (EP) market, but a new deal should give it a much-needed boost. The Marlborough, MA-based company said it will pay up to $300 million for Apama Medical, a privately-held firm that is trying to treat atrial fibrillation (AF) with a radiofrequency (RF) balloon that combines the best of catheter- and balloon-based ablation. The deal calls for an up-front cash payment of $175 million and another $125 million payment based on clinical and regulatory milestones expected over the period of 2018 through 2020. The acquisition is expected to clo...
Source: MDDI - October 4, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Cardiovascular Source Type: news

Brookwood Baptist surgeon receives coveted heart surgery fellowship
A Brookwood Baptist Health surgeon has received a coveted national fellowship and will bring a greater knowledge of heart surgery back to the Magic City. Cardiovascular and thoracic surgeon Dr. William McAlexander was selected out of 334 possible candidates for the 2017 James L. Cox Fellowship in Atrial Fibrillation Surgery, or Afib for short. "I’m honored to have the opportunity to participate in this immersive learning experience with guidance from top experts and leaders in the atrial fibrillation… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 3, 2017 Category: Biotechnology Authors: Tyler Patchen Source Type: news